[1] |
CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA.
Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208.
|
[2] |
LIU Xiaoping, LAI Xiangmao, OUYANG Zizhang, JIANG Sheng, ZHANG Ying.
Nobiletin inhibits neonatal rat cardiomyocytes hypertrophy induced by high glucose
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 753-759.
|
[3] |
DING Xueming, CHEN Tianpeng, XU Qiang, HE Huan, HE Ming.
Tetramethylpyrazine attenuates doxorubicin induced cardiotoxicity through 14-3-3γ/Bcl-2
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 361-367.
|
[4] |
XU Tiantian, WU Xiangyao, PI Aiwen, CHAI Hui, ZHANG Bin, WANG Bangcai, DOU Xiaobing, ZHU Linwensi.
Salvianolic acid A improves palmitie acid-induced lipotoxicity in cardiomyocyte via inhibiting TLR4/JNK MAPK
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 121-128.
|
[5] |
LIN Xiaoxin, WANG Zhenhua .
Study on the mechanism of miR-29a/HMGB1 signaling pathway on H9C2 cardiomyocyte fibrosis induced by high glucose and high fat
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1223-1232.
|
[6] |
ZHUO Fengqiao, HUANG Zhanhong, LIU Yujie.
Protective effect of Liquiritigenin on H9C2 cardiomyocytes apoptosis induced by high glucose
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 147-151.
|
[7] |
LI Jinyu, HUANG Danmei, ZHANG Yanmei, SHI Ganggang, WANG Bin.
Macrophage migration inhibitory factor protects H9c2 cardiac myocytes against hypoxia/reoxygenation injury through regulation of autophagy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 531-535.
|
[8] |
HAO Wei, SHEN Yuanyuan, ZHANG Junxiu, YANG Jieren.
Effects of sesamin combined with vitamin E on the cardiomyocyte apoptosis of spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1221-1227.
|
[9] |
LI Haigang, HU Shaiping, ZHOU Yi, XU Dandan, MA Ning, TANG Jing, BAO Meihua, ZHENG Xiahui.
Pharmacology progress on the main bioactive components of Ligusticum chuanxiong hort
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1302-1308.
|
[10] |
FU Yongjin, XIA Xueyi, ZHANG Xiaomu, LIU Yanbo, PAN Jingqiang, LV Junhua.
Effects of tetramethylpyrazine on the down-regulation of HMGB1 expression and reducing contents of RAGEs in diabetic nephropathy rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 846-851.
|
[11] |
JING Zhe, LIU Fengzhou, GUO Wenyun, JIAO Piqi, CHEN Yongqing.
Effect of allicin on apoptosis and Pink1/Parkin signal path of cardiomyocyte in db/db mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 601-605.
|
[12] |
WANG De-guo, WANG Xin, WANG An-cai, ZHU Hong-jun, SUN Xian-lin.
Effects of Taxol on the expression and distribution of connexin 43 in cultured cardiac myocytes under hypoxia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(9): 975-980.
|
[13] |
ZHANG Ze-yu, LIU Dan, WANG Qing, LUO Yong, LIAO Zhang-ping, TANG Lei, HE Ming.
Protective effect of tetramethylpyrazine preconditioning on rat myocardium with non-invasive limb ischemia preconditioning
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(12): 1353-1358.
|
[14] |
WAN Qing, PENG Yi-an, LIU Dan, HUANG Huang, LIU Ji-chun, HE Ming.
Effect of pretreatment with pentamethylquercetin on mitochondrial function in rat cardiomyocyte
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 1-5.
|
[15] |
CHEN Liang-jin, SHI Meng-qiong, HE Hai-bo, XIONG Xing-jun, LU Xun-cong.
Protective effects of total saponin from Panacis majoris rhizoma against H2O2-induced apoptosis in neonatal rat cardiomyocytes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(8): 860-867.
|